Literature DB >> 19195068

Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report.

Kun-Chun Chiang1, Jun Te Hsu, Huang-Yang Chen, Shyh Chuan Jwo, Tsann-Long Hwang, Yi Yin Jan, Chun-Nan Yeh.   

Abstract

Cystic neoplasms of the pancreas are relatively rare, comprising 10 percent of pancreatic cysts and only 1 percent of pancreatic cancers. Cystic neoplasms include mucinous cystic neoplasms, serous cystadenomas, papillary cystic tumors, cystic islet cell tumors and intraductal papillary mucinous neoplasms of the pancreas (IPMNs). IPMN was first described in 1982. It has been most commonly described in 60 to 70 years old males, and represents a relatively "new" but increasingly recognized disease. The improvement and widespread use of modern imaging equipments and heightened awareness of physicians contribute to the increasing incidence of IPMN. The majority of IPMNs are located in the pancreatic head (75%) while the rest involves the body/tail regions. Multifocal IPMNs have been hypothesized, but the true presence of multifocality is unknown. Here we present a 72-year-old male diagnosed with IPMN (carcinoma in situ) in the pancreatic head and a branch duct type IPMN (duct atypia) in the pancreatic body and tail. The patient underwent a Whipple intervention and a distal pancreatectomy. A three-year disease-free survival has been observed so far.

Entities:  

Mesh:

Year:  2009        PMID: 19195068      PMCID: PMC2653357          DOI: 10.3748/wjg.15.628

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Intraductal papillary mucinous tumor of the pancreas.

Authors:  James J Farrell; William R Brugge
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

2.  Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.

Authors:  B Terris; P Ponsot; F Paye; P Hammel; A Sauvanet; G Molas; P Bernades; J Belghiti; P Ruszniewski; J F Fléjou
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

3.  An aggressive resectional approach to cystic neoplasms of the pancreas.

Authors:  K D Horvath; J A Chabot
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

4.  Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography.

Authors:  Taro Hara; Taketo Yamaguchi; Takeshi Ishihara; Toshio Tsuyuguchi; Fukuo Kondo; Kazuki Kato; Takehide Asano; Hiromitsu Saisho
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

Review 5.  Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team.

Authors:  C Bassi; C Procacci; G Zamboni; A Scarpa; G Cavallini; P Pederzoli
Journal:  Int J Pancreatol       Date:  2000-06

6.  Spatial assessment by magnetic resonance cholangiopancreatography for preoperative imaging in partial pancreatic head resection.

Authors:  K Izuishi; T Nakagohri; M Konishi; K Inoue; H Tajiri; T Kinoshita
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

7.  Clinical management of intraductal papillary mucinous tumors of the pancreas based on imaging findings.

Authors:  T Wakabayashi; Y Kawaura; H Morimoto; K Watanabe; D Toya; Y Asada; Y Satomura; H Watanabe; T Okai; N Sawabu
Journal:  Pancreas       Date:  2001-05       Impact factor: 3.327

8.  Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.

Authors:  M Sugiyama; Y Izumisato; N Abe; T Masaki; T Mori; Y Atomi
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

9.  Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

Authors:  Michael D'Angelica; Murray F Brennan; Arief A Suriawinata; David Klimstra; Kevin C Conlon
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

10.  Mucin-hypersecreting carcinoma of the pancreas.

Authors:  Y Itai; T Kokubo; Y Atomi; A Kuroda; Y Haraguchi; A Terano
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

View more
  6 in total

1.  Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.

Authors:  Federica Castelli; Davide Bosetti; Riccardo Negrelli; Valerio Di Paola; Lisa Zantedeschi; Anna Ventriglia; Riccardo Manfredi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469

2.  Intraductal papillary mucinous neoplasm of the oesophagus: an unusual case of dysphagia.

Authors:  E Crighton; A Botha
Journal:  Ann R Coll Surg Engl       Date:  2012-03       Impact factor: 1.891

3.  Total invasion of the pancreatic gland by a rare aggressive IPMN: Report of a case.

Authors:  Marinos C Makris; Konstantinos C Koumarelas; Apostolos S Mitrousias; Christina N Karamveri; Evripidis P Yettimis; Adreas N Zevlas
Journal:  Int J Surg Case Rep       Date:  2013-07-16

4.  Small amounts of tissue preserve pancreatic function: Long-term follow-up study of middle-segment preserving pancreatectomy.

Authors:  Zipeng Lu; Jie Yin; Jishu Wei; Cuncai Dai; Junli Wu; Wentao Gao; Qing Xu; Hao Dai; Qiang Li; Feng Guo; Jianmin Chen; Chunhua Xi; Pengfei Wu; Kai Zhang; Kuirong Jiang; Yi Miao
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  Middle-preserving pancreatectomy: report of two cases and review of the literature.

Authors:  Kun Cheng; Bai-yong Shen; Cheng-hong Peng; Li-ma Na; Dong-feng Cheng
Journal:  World J Surg Oncol       Date:  2013-05-23       Impact factor: 2.754

Review 6.  The utilization of imaging features in the management of intraductal papillary mucinous neoplasms.

Authors:  Stefano Palmucci; Claudia Trombatore; Pietro Valerio Foti; Letizia Antonella Mauro; Pietro Milone; Roberto Milazzotto; Rosalia Latino; Giacomo Bonanno; Giuseppe Petrillo; Antonio Di Cataldo
Journal:  Gastroenterol Res Pract       Date:  2014-08-19       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.